Juha Öhman

Juha Öhman

Auto-generated profile, based on publicly available information

Juha Öhman

Department of Neurosurgery, Helsinki University Central Hospital, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1997 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
AMAndrew I. R. Maas
Andrew I. R. Maas
MDM. Dearden
M. Dearden
GTG. M. Teasdale
G. M. Teasdale
RBR. Braakman
R. Braakman
FCF. Cohadon
F. Cohadon
AUA. Unterberg
A. Unterberg
Guidelines for the management of severe head injury in adults as evolved by the European Brain Injury Consortium are presented and discussed. The importance of preventing and treating secondary insults is emphasized and the principles on which treatment is based are reviewed. Guidelines presented are of a pragmatic nature, based on consensus and expert opinion, covering the treatment from accident site to intensive care unit. Specific aspects pertaining to the conduct of clinical trials in head injury are highlighted. The adopted approach is further discussed in relation to other approaches to the development of guidelines, such as evidence based analysis.

22 March 1999 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
GMG. D. Murray
G. D. Murray
GTG. M. Teasdale
G. M. Teasdale
RBR. Braakman
R. Braakman
FCF. Cohadon
F. Cohadon
MDM. Dearden
M. Dearden
OCon behalf of the European Brain Injury Consortium
on behalf of the European Brain Injury Consortium

9 November 2008 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
KBKaya Bilguvar
Kaya Bilguvar
KYKatsuhito Yasuno
Katsuhito Yasuno
MNMika Niemelä
Mika Niemelä
YRYnte M Ruigrok
Ynte M Ruigrok
MFMikael von Und zu Fraunberg
Mikael von Und zu Fraunberg
MGMurat Günel
Murat Günel

15 April 2015 in Journal of Neurotrauma
Verified
Journal Article
Closed access
MWMinna Wäljas
Minna Wäljas
GIGrant L Iverson
Grant L Iverson
RLRael T. Lange
Rael T. Lange
UHUllamari Hakulinen
Ullamari Hakulinen
PDPrasun Dastidar
Prasun Dastidar
JÖJuha Öhman
Juha Öhman
This study examined multiple biopsychosocial factors relating to post-concussion symptom (PCS) reporting in patients with mild traumatic brain injuries (mTBI), including structural (computed tomography and magnetic resonance imaging [MRI]) and microstructural neuroimaging (diffusion tensor imaging [DTI]). Patients with mTBIs completed several questionnaires and cognitive testing at approximately one month ( n =126) and one year ( n =103) post-injury. At approximately three weeks post-injury, DTI was undertaken using a Siemens 3T scanner in a subgroup ( n =71). Measures of fractional anisotropy were calculated for 16 regions of interest (ROIs) and measures of apparent diffusion coefficient were calculated for 10 ROIs. Patients were compared with healthy control subjects. Using International Classification of Diseases, Tenth Revision (ICD-10) PCS criteria and mild or greater symptom reporting, 59% of the mTBI sample met criteria at one month and 38% met criteria at one year. However, 31% of the healthy control sample also met criteria for the syndrome—illustrating a high false-positive rate. Significant predictors of ICD-10 PCS at one month were pre-injury mental health problems and the presence of extra-cranial bodily injuries. Being symptomatic at one month was a significant predictor of being symptomatic at one year, and depression was significantly related to PCS at both one month and one year. Intracranial abnormalities visible on MRI were present in 12.1% of this sample, and multifocal areas of unusual white matter as measured by DTI were present in 50.7% (compared with 12.4% of controls). Structural MRI abnormalities and microstructural white matter findings were not significantly associated with greater post-concussion symptom reporting. The personal experience and reporting of post-concussion symptoms is likely individualized, representing the cumulative effect of multiple variables, such as genetics, mental health history, current life stress, medical problems, chronic pain, depression, personality factors, and other psychosocial and environmental factors. The extent to which damage to the structure of the brain contributes to the persistence of post-concussion symptoms remains unclear.

1 January 1989 in Journal of Neurosurgery
Verified
Journal Article
Closed access
JÖJuha Öhman
Juha Öhman
OHOlli Heiskanen
Olli Heiskanen
✓ A total of 216 patients with a ruptured aneurysm of the anterior part of the circle of Willis were enrolled into this prospective randomized study of timing of the operation after aneurysmal subarachnoid hemorrhage (SAH). Only patients in clinical Grades I to III (according to the classification of Hunt and Hess) who were admitted and randomly assigned to a treatment group within 72 hours after the SAH were included in the trial. The patients were randomly assigned to one of three operation groups: acute surgery (AS: 0 to 3 days after the SAH; day of SAH = Day 0), intermediate surgery (IS: 4 to 7 days after the SAH), or late surgery (LS: 8 days to an indefinite time after the SAH). Three patients (4.3%) in the IS group and six patients (8.6%) in the LS group died before surgery was undertaken. At 3 months post-SAH, 65 patients (91.5%) from the AS group were classified as independent compared to 55 (78.6%) from the IS group and 56 (80.0%) from the LS group. The management mortality rate in the AS group was 5.6% compared to 12.9% in the LS group. Of the 216 patients enrolled in the timing study, 159 were randomly assigned to an independent double-blind placebo-controlled trial of nimodipine in Grade I to III patients. A total of 79 patients received nimodipine and 80 placebo. When the nimodipine group and the no-nimodipine group (the 80 placebo-treated patients plus the 52 patients who were not entered into the nimodipine trial) were analyzed separately, a significant difference was seen in the outcome of the no-nimodipine group (dependent AS vs. dependent IS, p = 0.01). Nimodipine treatment was associated with a significant reduction of delayed ischemic deterioration (all operation groups combined, nimodipine vs. no nimodipine p = 0.01; LS with nimodipine vs. LS with no nimodipine, p = 0.03).

20 February 2014 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
GSGyörgy K Sandor
György K Sandor
JNJura Numminen
Jura Numminen
JWJan Wolff
Jan Wolff
TTTuomo Thesleff
Tuomo Thesleff
AMAimo Miettinen
Aimo Miettinen
JÖJuha Öhman
Juha Öhman
Although isolated reports of hard-tissue reconstruction in the cranio-maxillofacial skeleton exist, multipatient case series are lacking. This study aimed to review the experience with 13 consecutive cases of cranio-maxillofacial hard-tissue defects at four anatomically different sites, namely frontal sinus (3 cases), cranial bone (5 cases), mandible (3 cases), and nasal septum (2 cases). Autologous adipose tissue was harvested from the anterior abdominal wall, and adipose-derived stem cells were cultured, expanded, and then seeded onto resorbable scaffold materials for subsequent reimplantation into hard-tissue defects. The defects were reconstructed with either bioactive glass or β-tricalcium phosphate scaffolds seeded with adipose-derived stem cells (ASCs), and in some cases with the addition of recombinant human bone morphogenetic protein-2. Production and use of ASCs were done according to good manufacturing practice guidelines. Follow-up time ranged from 12 to 52 months. Successful integration of the construct to the surrounding skeleton was noted in 10 of the 13 cases. Two cranial defect cases in which nonrigid resorbable containment meshes were used sustained bone resorption to the point that they required the procedure to be redone. One septal perforation case failed outright at 1 year because of the postsurgical resumption of the patient's uncontrolled nasal picking habit.